Popular Articles

Clinipace To Manage Two Phase II Clinical Trials For Inspire Pharmaceuticals
Clinipace, a digital clinical research organization, announced that Inspire Pharmaceuticals, Inc. has selected the company to manage and deploy two phase II studies for the ophthalmic prescription medicine, AzaSite®.

Employing People With Autism Could Save The UK Economy Billions Each Year
A unique event to discuss Autism and employment was held at Goldsmiths, University of London this week. For the first time charities, researchers, business and government were brought together to look at how people with Autism, and related disorders, can be supported effectively into employment.
News of the day
Afinitor(R) (everolimus) Recommended For Use In The European Union For Patients With Advanced Renal Cell Carcinoma
Novartis has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) supporting European Union (EU) approval of everolimus for the treatment of patients with advanced renal cell carcinoma (RCC)3, the most common type of kidney cancer4.
Oncology

Interim Study Results Presented At ADA 2009: Exenatide Not Associated With Increased Rate Of Acute Pancreatitis Compared To Other Antidiabetic Drugs

from two national surveys. Int J Clin Pract. 2007;61:737-47. (vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61-78. (vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr. 2003;22:331-9. Amylin Pharmaceuticals, Inc

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):